Biden Administration’s Access Model Offers Hope For Gene Therapies

WASHINGTON, DC: Centers for Medicare and Medicaid Services Administrator Chiquita Brooks-LaSure … [+] announced on December 5th that the manufacturers of the sickle cell disease gene therapies, Lyfgenia and Casgevy, have entered into agreements…